Summary of Purpose
Currently, early reperfusion is considered as the most effective therapy for the treatment of acute ischemic stroke (AIS). Over the past 20 years, intravenous tissue plasminogen activator (IV tPA) has been demonstrated to be the only effective therapy for AIS. More recently, several large randomized clinical trials have concluded the superiority of endovascular mechanical thrombectomy for AIS. Furthermore, with...Read More →
The following dates are available for this trial. Trial information last updated on 20 December 2017.
|7 Jul 2017||26 Jun 2017||17 Sep 2017||20 Dec 2017||1 Dec 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Xunming JI, MD
- Wenbo Zhao, MD